To secure funding in today’s market, life sciences companies need to show how their financial, operational, and strategic plans work together in practice.
Interest is rising in life‑science pipelines, and companies that succeed combine strong science with disciplined financial and operational foundations.
If you’re expanding into the U.S., early decisions around IP, intercompany agreements, and documentation can create risk—or set you up for smoother fundraising, tax savings,...
SOC reports are often discussed as if they are interchangeable. In practice, that assumption breaks down quickly. A SOC 1 report is not a general...
Strong internal controls under SOX 404(a) help organizations prevent errors, improve operational consistency, and maintain confidence with stakeholders. Effective compliance turns regulatory requirements into a...
Key Takeaways: Program-level review helps identify where resources are stretched and which programs need strategic attention. Combining financial results with mission contribution supports intentional, data-informed...
Key takeaways: IRS updates FAQs on business interest expense deductions under Section 163(j). New rules allow adding back depreciation, amortization, and depletion when calculating adjusted...
When preparing a business for sale, one of the first areas buyers examine is tax compliance. Where a company files state income, sales, and payroll...
Life sciences companies face some of the highest costs and longest timelines for research and development. The One Big Beautiful Bill (OBBB) Act, with the...
